Lichen Planus
Dermatology, Venereology & Leprosy · Topic 4
Source: NMC CBME Curriculum 2024 · Volume II · Dermatology, Venereology & Leprosy · Topic 4 · combined PDF page 356
Practice questions
- Which clinical form of oral lichen planus is reported as the most common?
- A patient with OLP has widespread oral erosions. Which statement best characterizes this clinical form?
- Which description best matches atrophic oral lichen planus in the supplied consensus?
- Which immune-cell mechanism is proposed in the supplied consensus to contribute to oral lichen planus?
- Which demographic profile is most consistent with the supplied descriptions of oral lichen planus?
- The Italian consensus gives an estimated global population frequency of oral lichen planus of approximately:
- Which statement about the etiology of oral lichen planus is best supported by the supplied literature?
- A clinician is considering an OLP diagnosis in a patient with an oral mucosal lesion. Which approach is emphasized by the AAOMP position paper?
- After an initial biopsy interpreted as compatible with oral lichen planus, what is an important next step in the diagnostic process?
- A lesion initially considered OLP later raises concern for a mimic. Which further diagnostic evaluation is supported by the AAOMP position paper?
- Which group contains only oral lesions identified in the supplied review as important OLP differentials or mimics?
- How is oral lichen planus classified in the practical management review with respect to oral cancer risk?
- A recent narrative review summarized approximate malignant transformation rates for OLP. Which pairing matches its reported estimates?
- Given the reported potential for malignant transformation in OLP, which follow-up approach is supported by the supplied review?
- Which management statement best reflects the supplied consensus on oral lichen planus?
- A patient with symptomatic OLP needs coordinated care. Which approach is specifically supported by the Italian consensus?
- A patient with a suspected OLP lesion has a local irritant and an uncertain diagnosis. Which sequence is consistent with the stepwise approach described in the practical management review?
- What is the most evidence-aligned interpretation of the relationship between oral lichen planus and diabetes mellitus?
- A clinician considers apremilast for a patient with treatment-refractory OLP. Which statement best reflects the supplied systematic review?
- In the systematic review of apremilast for lichen planus, what proportion of the included patients achieved remission?
- Which limitation most directly prevents firm conclusions about long-term apremilast effectiveness in lichen planus?
- Which finding from the topical JAK inhibitor systematic review most strongly supports further study of these agents in frontal fibrosing alopecia?
- What is the evidence status of topical ruxolitinib for cutaneous lichen planus in the supplied systematic review?
- A patient asks whether topical JAK inhibitors should now be used routinely for all lichen planus phenotypes. Which response best fits the systematic review?
- A systematic review of photobiomodulation for oral lichen planus reports possible improvement in pain and lesion size. What is the most appropriate interpretation of these findings?
- Which outcomes were specifically considered in the photobiomodulation systematic review of oral lichen planus and recurrent aphthous stomatitis?
- A clinician is reviewing a suspected OLP case in which the clinical appearance and pathology are discordant. Which principle should guide the next diagnostic decision?
- Which statement best summarizes the treatment evidence for lichen planus across apremilast and topical JAK inhibitor reviews?
- Which statement about symptoms in oral lichen planus is most consistent with the supplied guideline?
- A clinician is asked whether improvement of oral symptoms means OLP has been cured. Which response is most appropriate based on the supplied consensus?
- Which statement best characterizes the evidence base for topical JAK inhibitors in lichen planus pigmentosus and nail lichen planus?
- In the supplied apremilast systematic review, which subtype was most commonly represented among treated patients?